Logo image of PEAK

HEALTHPEAK PROPERTIES INC (PEAK) Stock Price, Forecast & Analysis

USA - NYSE:PEAK - US42250P1030 - REIT

17.1 USD
+0.35 (+2.09%)
Last: 3/1/2024, 8:04:00 PM
17.1 USD
0 (0%)
After Hours: 3/1/2024, 8:04:00 PM

PEAK Key Statistics, Chart & Performance

Key Statistics
Market Cap9.36B
Revenue(TTM)2.18B
Net Income(TTM)304.29M
Shares547.17M
Float546.09M
52 Week High24.46
52 Week Low15.24
Yearly Dividend1.2
Dividend Yield7.02%
EPS(TTM)0.56
PE30.54
Fwd PE43.73
Earnings (Next)N/A N/A
IPO1985-05-23
Sector
GICS SectorReal Estate
GICS IndustryDiversified REITs
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS SubIndustryHealth Care REITs


PEAK short term performance overview.The bars show the price performance of PEAK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

PEAK long term performance overview.The bars show the price performance of PEAK in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of PEAK is 17.1 USD. In the past month the price decreased by -9.14%. In the past year, price decreased by -29.57%.

HEALTHPEAK PROPERTIES INC / PEAK Daily stock chart

PEAK Latest News, Press Relases and Analysis

PEAK Competitors/Peers

The largest stocks on the US markets in the "Health Care REITs" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
WELL WELLTOWER INC 136.05 131.94B
VTR VENTAS INC 151.92 35.90B
OHI OMEGA HEALTHCARE INVESTORS 23.75 13.03B
DOC HEALTHPEAK PROPERTIES INC 86.45 12.02B
ARE ALEXANDRIA REAL ESTATE EQUIT N/A 8.79B
CTRE CARETRUST REIT INC 26.55 8.12B
AHR AMERICAN HEALTHCARE REIT INC 104.15 8.08B
HR HEALTHCARE REALTY TRUST INC N/A 6.36B
SBRA SABRA HEALTH CARE REIT INC 25.82 4.46B
DHCNL DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 N/A 4.29B
DHCNI DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 N/A 4.28B
NHI NATL HEALTH INVESTORS INC 25.69 3.70B

About PEAK

Company Profile

PEAK logo image Healthpeak Properties, Inc. is a real estate investment trust, which engages in the acquisition, development, ownership, and management of healthcare real estate. The company is headquartered in Denver, Colorado and currently employs 199 full-time employees. The firm acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in a diversified portfolio of high-quality healthcare properties across three core asset classes of life science, medical office, and continuing care retirement community (CCRC) real estate. The Company’s segments include Life science, Medical office, and CCRC. The Life Science segment properties contain laboratory and office space, which is leased primarily to biotechnology, medical device, and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The firm's Medical Office segment includes medical office buildings (MOBs) and hospitals. MOBs typically contain physicians’ offices and examination rooms and may also include pharmacies, hospital ancillary service space, and outpatient services.

Company Info

HEALTHPEAK PROPERTIES INC

4600 South Syracuse Street, Suite 500

Denver COLORADO 80237 US

CEO: Thomas M. Herzog

Employees: 199

PEAK Company Website

Phone: 19494070700

HEALTHPEAK PROPERTIES INC / PEAK FAQ

Can you describe the business of HEALTHPEAK PROPERTIES INC?

Healthpeak Properties, Inc. is a real estate investment trust, which engages in the acquisition, development, ownership, and management of healthcare real estate. The company is headquartered in Denver, Colorado and currently employs 199 full-time employees. The firm acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in a diversified portfolio of high-quality healthcare properties across three core asset classes of life science, medical office, and continuing care retirement community (CCRC) real estate. The Company’s segments include Life science, Medical office, and CCRC. The Life Science segment properties contain laboratory and office space, which is leased primarily to biotechnology, medical device, and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The firm's Medical Office segment includes medical office buildings (MOBs) and hospitals. MOBs typically contain physicians’ offices and examination rooms and may also include pharmacies, hospital ancillary service space, and outpatient services.


Can you provide the latest stock price for HEALTHPEAK PROPERTIES INC?

The current stock price of PEAK is 17.1 USD. The price increased by 2.09% in the last trading session.


Does PEAK stock pay dividends?

HEALTHPEAK PROPERTIES INC (PEAK) has a dividend yield of 7.02%. The yearly dividend amount is currently 1.2.


What is the ChartMill rating of HEALTHPEAK PROPERTIES INC stock?

PEAK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What do analysts say about HEALTHPEAK PROPERTIES INC (PEAK) stock?

22 analysts have analysed PEAK and the average price target is 22.19 USD. This implies a price increase of 29.74% is expected in the next year compared to the current price of 17.1.


Can you provide the upcoming dividend date for HEALTHPEAK PROPERTIES INC?

The next ex-dividend date for HEALTHPEAK PROPERTIES INC (PEAK) is February 13, 2024.


Is HEALTHPEAK PROPERTIES INC (PEAK) expected to grow?

The Revenue of HEALTHPEAK PROPERTIES INC (PEAK) is expected to grow by 15.38% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


PEAK Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PEAK Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PEAK. PEAK has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PEAK Financial Highlights

Over the last trailing twelve months PEAK reported a non-GAAP Earnings per Share(EPS) of 0.56. The EPS decreased by -38.86% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.95%
ROA 1.94%
ROE 4.79%
Debt/Equity 1.08
Chartmill High Growth Momentum
EPS Q2Q%1200%
Sales Q2Q%5.56%
EPS 1Y (TTM)-38.86%
Revenue 1Y (TTM)5.81%

PEAK Forecast & Estimates

22 analysts have analysed PEAK and the average price target is 22.19 USD. This implies a price increase of 29.74% is expected in the next year compared to the current price of 17.1.

For the next year, analysts expect an EPS growth of -30.18% and a revenue growth 15.38% for PEAK


Analysts
Analysts78.18
Price Target22.19 (29.77%)
EPS Next Y-30.18%
Revenue Next Year15.38%

PEAK Ownership

Ownership
Inst Owners117.78%
Ins Owners0.15%
Short Float %N/A
Short RatioN/A